We report a simple method to convert RBCs into efficient microreactors for important biomedical applications. A commonly used cell membrane permeation agent Triton X-100 (TX) was employed at finely tuned concentrations to punch pores in the membranes and render RBCs highly permeable to substrates while maintaining membrane integrity. Subsequently, low concentration of the fixative agent glutaraldehyde (GA) was used to stabilize the cells and avoid inactivation of the membrane proteins. Atomic force microscopy (AFM) and measurement of Young’s modulus (YM) values clearly demonstrated that the reformed RBCs (Ref-RBCs) retained their size, the biconcave disk-like shape, elasticity, and mechanical flexibility comparable to natural RBCs. Furthermore, Ref-RBCs improve the blood survival time of loaded enzymes, and have high permeability to substrate molecules. By exploiting these properties of Ref-RBCs microreactors, we developed an important biomedical application of blood detoxification. When uric acid (UA) and KCN were used as endogenous and exogenous toxin models, respectively, Ref-RBCs, loaded with the corresponding detoxifying enzymes, showed much faster toxin clearance rates than the unmodified RBCs both in vitro and in an in vivo animal model. Our results suggest that these microreactors, after confirming biocompatibility, would have promising therapeutic applications, especially in blood and liver-related diseases.